Chlorthalidone
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Chlorthalidone is a thiazide-like diuretic with a longer half-life and stronger evidence base than hydrochlorothiazide. It was the diuretic used in the landmark ALLHAT and SHEP trials. Major guidelines increasingly favor chlorthalidone over HCTZ for hypertension due to superior 24-hour blood pressure control and proven cardiovascular event reduction.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Chlorthalidone is a thiazide-like diuretic with a longer half-life and stronger evidence base than hydrochlorothiazide. NutriStack rates the supporting evidence as strong. Common adult dosing is 12.5–25 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete potassium, magnesium, zinc. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: superior 24-hour blood pressure control compared to hctz, proven cardiovascular event and stroke reduction (allhat, shep), long duration of action allows once-daily dosing. 10 sources indexed (2021–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inhibits sodium reabsorption at the distal convoluted tubule, similar to thiazides but with a longer duration of action. Also has some carbonic anhydrase inhibitory activity. Reduces plasma volume initially, then decreases peripheral vascular resistance with chronic use. Extensively binds to carbonic anhydrase in red blood cells, contributing to its long half-life.
Dosing & protocol.
Can be taken with or without food; take in the morning to avoid nocturia
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Potassium
ModerateThiazide diuresis can increase distal sodium delivery and urinary potassium secretion, so potassium should be monitored rather than self-repleted.
Magnesium
ModerateThiazides can increase urinary magnesium losses and contribute to low magnesium status.
Zinc
MildChronic thiazide use can increase urinary zinc excretion and gradually lower zinc balance.
Sodium
ModerateThiazides are a common medication cause of hyponatremia, especially in older adults.
CoQ10
MildBeta-blocker and diuretic therapy are associated with lower CoQ10 status in some long-term users, likely through increased oxidative demand and reduced tissue levels.
Full safety detail.
Side effects
- Hypokalemia (more than HCTZ due to longer action)
- Hyponatremia
- Hyperuricemia and gout
- Hyperglycemia
- Dizziness
- Photosensitivity
- Hyperlipidemia
- Erectile dysfunction
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Efficacy & safety of chlorthalidone vs. hydrochlorothiazide in hypertension: A systematic review & meta-analysisPMIDAggarwal P, Oza RR, Solanki H et al. · The Indian journal of medical research · 2025
Aggarwal P, Oza RR, Solanki H et al.. Efficacy & safety of chlorthalidone vs. hydrochlorothiazide in hypertension: A systematic review & meta-analysis. The Indian journal of medical research. 2025
- 2Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-AnalysisPMIDKhenhrani RR, Nnodebe I, Rawat A et al. · Cureus · 2023
Khenhrani RR, Nnodebe I, Rawat A et al.. Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis. Cureus. 2023
- 3Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-AnalysisPMIDKumar L, Khuwaja S, Kumar A et al. · Cureus · 2023
Kumar L, Khuwaja S, Kumar A et al.. Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis. Cureus. 2023
- 4Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic ReviewPMIDKatsi V, Michalakeas C, Soulaidopoulos S et al. · Current hypertension reviews · 2021
Katsi V, Michalakeas C, Soulaidopoulos S et al.. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Current hypertension reviews. 2021
- 5Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patientsPMIDDineva S, Uzunova K, Pavlova V et al. · Blood pressure monitoring · 2021
Dineva S, Uzunova K, Pavlova V et al.. Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients. Blood pressure monitoring. 2021
Reference material
5- 6ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA. 2002.Source linkedPMID
- 7SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (SHEP). JAMA. 1991.Source linkedPMID
- 8Oliveira AV et al. Thiazide and thiazide-like diuretics for kidney stones recurrence: a systematic review and network meta-analysis of randomised controlled trials. World J Urol. 2025.Source linkedPMID
- 9Ernst ME, Fravel MA. Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide. American journal of hypertension. 2022Source linkedPMID
- 10Ishani A, Cushman WC, Leatherman SM et al.. Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. The New England journal of medicine. 2022Source linkedPMID
Common questions.
Quick answers about Chlorthalidone, drawn from the data on this page.
What is Chlorthalidone?
Chlorthalidone is a thiazide-like diuretic with a longer half-life and stronger evidence base than hydrochlorothiazide. It was the diuretic used in the landmark ALLHAT and SHEP trials. Major guidelines increasingly favor chlorthalidone over HCTZ for hypertension due to superior 24-hour blood pressure control and proven cardiovascular event reduction.
What is Chlorthalidone used for?
Commonly cited benefits of Chlorthalidone include: Superior 24-hour blood pressure control compared to HCTZ; Proven cardiovascular event and stroke reduction (ALLHAT, SHEP); Long duration of action allows once-daily dosing; Low cost. NutriStack rates the overall evidence as strong.
What is a typical dose of Chlorthalidone?
A typical adult dose of Chlorthalidone is 12.5–25 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Chlorthalidone?
Reported side effects include hypokalemia (more than hctz due to longer action), hyponatremia, hyperuricemia and gout, hyperglycemia, dizziness, photosensitivity. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Chlorthalidone?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Chlorthalidone in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.